rxstat › Shortages › Zidovudine Lamivudine

Zidovudine Lamivudine (Combivir) shortage status

Shortage anticipated

Source: Health Canada shortage reports · Updated Jul 23, 2026

A shortage of Zidovudine Lamivudine is anticipated but not yet confirmed. 1 product(s) have anticipated-shortage reports on file with Health Canada.

A combination antiretroviral used to treat HIV infection.

Products affected
0 / 5
Reports on file
8

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Anticipated
APO-LAMIVUDINE-ZIDOVUDINE
300MG 150MG · TABLET · APOTEX INC
DIN 02375540 · Disruption of the manufacture of the drug.
To be discontinued
AURO-LAMIVUDINE/ZIDOVUDINE
150MG 300MG · TABLET · AURO PHARMA INC
DIN 02414414
Discontinued
COMBIVIR
300MG 150MG · TABLET · VIIV HEALTHCARE ULC
DIN 02239213
Resolved
JAMP LAMIVUDINE / ZIDOVUDINE
150MG 300MG · TABLET · JAMP PHARMA CORPORATION
DIN 02502801 · ended May 9, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-LAMIVUDINE-ZIDOVUDINE
300MG 150MG · TABLET · APOTEX INC
DIN 02375540 · ended Jan 19, 2023 · Disruption of the manufacture of the drug.
Resolved
AURO-LAMIVUDINE/ZIDOVUDINE
300MG 150MG · TABLET · AURO PHARMA INC
DIN 02414414 · ended Nov 30, 2021 · Demand increase for the drug.
Discontinued
TEVA-LAMIVUDINE/ZIDOVUDINE
300MG 150MG · TABLET · TEVA CANADA LIMITED
DIN 02387247
Resolved
APO-LAMIVUDINE-ZIDOVUDINE
300MG 150MG · TABLET · APOTEX INC
DIN 02375540 · ended Jun 29, 2018 · Disruption of the manufacture of the drug.

What's happening

A manufacturer has told Health Canada it expects supply of Zidovudine Lamivudine to fall short of demand. Anticipated shortages sometimes resolve without patients noticing; this page updates as soon as the status changes.

Zidovudine Lamivudine is classified under “DIRECT ACTING ANTIVIRALS” (ATC J05AR).

Recent changes

Common questions

What is Zidovudine Lamivudine used for?

A combination antiretroviral used to treat HIV infection.

When will Zidovudine Lamivudine be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Zidovudine Lamivudine in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (direct acting antivirals)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Inosine Pranobex (Imunovir) No current shortage Letermovir (Prevymis) No current shortage Nirmatrelvir Ritonavir (Paxlovid) No current shortage Adefovir Dipivoxil (Hepsera) Partial shortage 1 of 2 reported products affected Atazanavir (Reyataz) Partial shortage 3 of 8 reported products affected Baloxavir Marboxil (Xofluza) Partial shortage 1 of 1 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.